Keyword Search 2010 | 2009 | 2008 | 2007 | 2006 Date Title   02/03/10 Acorda Therapeutics to Present at the 12th Annual BIO CEO & Investor Conference 02/03/10 Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRATM (dalfampridine) 01/25/10 Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development 01/22/10 Acorda Therapeutics Announces FDA Approval of AMPYRA(TM) (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed 01/04/10 Acorda Therapeutics to Present at the 28th Annual JPMorgan Healthcare Conference